Review
Copyright ©The Author(s) 2016.
World J Orthop. Jan 18, 2016; 7(1): 20-29
Published online Jan 18, 2016. doi: 10.5312/wjo.v7.i1.20
Figure 1
Figure 1 Degenerative changes that contribute to extrinsic compression of the spinal cord in cervical myelopathy. OPLL: Ossification of the posterior longitudinal ligament.
Figure 2
Figure 2 Determination of the anteroposterior compression ratio in patients with cervical myelopathy. AP = b/a × 100. Reprinted with permission. AP: Anteroposterior compression ratio.
Figure 3
Figure 3 Cellular mechanisms involved in cervical myelopathy. The hypoxia/ischemia cascade results from chronic progressive compression of the cervical spinal cord. This induces extracellular (TNF-α) and intracellular pro-apoptotic pathways (p-53, JNK), induces neuroinflammation and ultimately, neuronal and oligodendrocyte destruction. Additionally, compromise of the BSCB results from ischemia-induced endothelial cell loss. Increased BSCB permeability alters the cellularity of the spinal cord microenvironment and is thought to further potentiate neuroinflammation. These mechanisms contribute to the upper limb dysfunction, spasticity, and gait disturbances observed in human cervical spondylotic myelopathy. BSCB: Blood-spinal cord barrier; TNF-α: Tumor necrosis factor-α.